CERBA HEALTHCARE in the news
Advanced medical diagnosis and prevention
Tamtam found 20 recent articles about CERBA HEALTHCARE.
- Julien Samson nouveau PDG du groupe Cerba HealthCare
Julien Samson will become CEO of Cerba HealthCare in June 2025, leading its growth and transformation with extensive health sector experience.
- Julien Samson new CEO of Cerba HealthCare Group
Julien Samson will become CEO of Cerba HealthCare in mid-2025, leading its growth and transformation in medical biology services.
- Julien Samson, nouveau CEO du groupe Cerba HealthCare
Julien Samson becomes CEO of Cerba HealthCare, focusing on company transformation and sustaining its leadership in medical diagnostics.
- Longevity medicine: Italians like it if it is concrete and accessible: +138% of registrations for Longevity by Cerba HealthCare Italia since the beginning of the year
Cerba HealthCare Italia's Longevity program sees a significant rise in registrations, indicating a shift towards proactive health management among Italians.
- Mars finalise l’acquisition des parts des entreprises françaises de diagnostic vétérinaire Cerba Vet et ANTAGENE détenues par le groupe Cerba HealthCare
Mars completed the acquisition of Cerba HealthCare's shares in Cerba Vet and ANTAGENE, enhancing its veterinary diagnostics and pet health services portfolio.
- Inter guests at the Cerba Healthcare Lombardia special event
Cerba Healthcare Lombardia hosted an event with Inter Milan to promote B2B ties and strengthen their partnership.
- Mars Incorporated entre en discussions exclusives en vue d'acquérir la totalité des parts des entreprises françaises de diagnostic vétérinaire Cerba Vet et ANTAGENE détenues par le groupe Cerba HealthCare
Mars is negotiating to acquire French veterinary diagnostic companies Cerba Vet and ANTAGENE from Cerba HealthCare to expand its animal health diagnostics business.
- Cerba HealthCare and Nexus Gulf Healthcare announce strategic joint venture
Cerba HealthCare and Nexus Gulf Healthcare established a joint venture in Saudi Arabia to enhance clinical pathology services aligned with Vision 2030 healthcare reforms.
- Cerba Healthcare to acquire Canadian contract research laboratory Cirion Biopharma Research to expand bioanalytical capabilities and shorten time-to-deploy complex clinical trials
Cerba HealthCare acquired Canadian CRO CIRION to enhance bioanalytical capabilities and expand its North American clinical trial services.
- RECHERCHE CLINIQUE : CERBA HEALTHCARE FAIT L’ACQUISITION AU CANADA DU LABORATOIRE CIRION BIOPHARMA RESEARCH, PERMETTANT DE RENFORCER SES CAPACITÉS BIOANALYTIQUES ET RÉDUIRE LES DÉLAIS DE DEMARRAG
Cerba HealthCare acquired Canadian CRO Cirion Biopharma Research to strengthen its bioanalytical and clinical trial laboratory services, enhancing its North American presence and capabilities in personalized medicine.
- Cerba Research partners with the Gustave Roussy Institute to improve patient experience
Cerba Research collaborates with Gustave Roussy to improve patient experience in immuno-oncology trials through a new digital tool.
- Cerba Research unifie la gestion de la Qualité avec Veeva Vault Quality Suite
Cerba Research is enhancing its quality management with Veeva Vault Quality Suite for better efficiency and compliance.
- Cerba Research Unifies Quality Processes with Veeva Vault Quality Suite
Cerba Research is enhancing its quality operations by implementing Veeva Vault Quality Suite for better efficiency and compliance.
- Ex-Lancet CEO demands Sh3.5bn amid board row
Former Lancet Kenya CEO Ahmed Kalebi is suing for Sh3.6 billion over shareholder disputes and alleged financial misconduct.
- Green light to the acquisition of the Labexa Group by the Cerba Group, subject to conditions
Cerba Group's acquisition of Labexa is approved with conditions to ensure competition in Hautes-Pyrénées.
- Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Clinical Trials
Cerba HealthCare is acquiring Viroclinics-DDL to expand its clinical trial and virology services globally, enhancing its diagnostic and drug development capabilities.
- Cerba Healthcare taps two high yield bonds for Lifebrain buyout
Cerba Healthcare is securing €500 million in high yield bonds for its Lifebrain acquisition financing.
- Orrick Advises Cerba HealthCare in Acquisition of Lifebrain
Cerba HealthCare is set to acquire Lifebrain, enhancing its outpatient diagnostics capabilities.
- Investindustrial's Lifebrain nears sale to Cerba HealthCare
Cerba HealthCare is nearing a deal to acquire Lifebrain from Investindustrial.
- The new big data application that is reshaping clinical trials
A Cerba Healthcare doctor developed a digital patient recruitment system that speeds up clinical trial enrollment by leveraging routine lab data, improving patient engagement and reducing costs.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like CERBA HEALTHCARE?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies